Pharmacy

Galamer Razadyne

Home » Prescription Drugs 8 » Galamer Razadyne

Galantamine is indicated in the treatment of Mild-to-moderate Alzheimer's disease.Galantamine can delay or even reverse mental decline in some patients with mild to moderate Alzheimer's disease. It is thought to work by boosting levels of the chemical messenger acetylcholine in the brain. (In Alzheimer's disease the cells that produce acetylcholine slowly deteriorate.) Galantamine improves the function of nerve cells in the brain. It works by preventing the breakdown of a chemical called acetylcholine (ah see til KO leen). People with dementia usually have lower levels of this chemical which is important for the processes of memory thinking and reasoning.Galantamine is used to treat mild to moderate dementia caused by Alzheimer's disease.

Buy Galamer Razadyne and other Prescription Drugs 8 products online at Medstore.

Buy Online at Medstore - Click Here!

About Galamer Razadyne:

Product Type: Prescription Drugs 8

Galamer (Razadyne Reminyl Generic Galantamine)

Galamer (Razadyne Reminyl Generic Galantamine)

Razadyne Reminyl Generic Galantamine

4mg 50 Tablets 4mg 100(2 x 50) Tablets 4mg 200(4 x 50) Tablets 8mg 50 Tablets 8mg 100(2 x 50) Tablets 8mg 200(4 x 50) Tablets Razadyne Reminyl Generic Galantamine Galamer

View more Prescription Drugs 8

Previous Product  Next Product

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.